Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02156804
What this trial is testing

A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172)

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,009
Post-approval studies (Phase 4)Active Not RecruitingNCT06121401
What this trial is testing

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

Who this might be right for
Carcinoma, Ovarian Epithelial
Mario Negri Institute for Pharmacological Research 190
Testing effectiveness (Phase 2)Looking for participantsNCT07439653
What this trial is testing

TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

Who this might be right for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
TORL Biotherapeutics, LLC 155
Testing effectiveness (Phase 2)UnknownNCT02576561
What this trial is testing

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

Who this might be right for
Human PapillomavirusHigh-Grade Squamous Intraepithelial Lesions
THEVAX Genetics Vaccine 10
Testing effectiveness (Phase 2)Study completedNCT02301897
What this trial is testing

A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 43
Testing effectiveness (Phase 2)Study completedNCT03112590
What this trial is testing

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, MaleBreast Cancer Female+1 more
H. Lee Moffitt Cancer Center and Research Institute 51
Not applicableUnknownNCT05596370
What this trial is testing

Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer

Who this might be right for
Pancreatic CancerCholangiocarcinomaGallbladder Cancer
Seoul National University Hospital 150
Not applicableUnknownNCT03043508
What this trial is testing

Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

Who this might be right for
Genetic MutationMEN1
M.D. Anderson Cancer Center 45
Early research (Phase 1)Ended earlyNCT00747825
What this trial is testing

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Molecular Insight Pharmaceuticals, Inc. 12
Not applicableStudy completedNCT03628417
What this trial is testing

Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases

Who this might be right for
Cutaneous Melanoma
Szeged University 7
Testing effectiveness (Phase 2)UnknownNCT00886028
What this trial is testing

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
National Institute of Cancerología 31
Not applicableActive Not RecruitingNCT01352429
What this trial is testing

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Abramson Cancer Center at Penn Medicine 303
Not applicableEnded earlyNCT01616537
What this trial is testing

Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter

Who this might be right for
Malignant Mast Cell TumorsSolid Organ Sites
Centre Antoine Lacassagne 990
Large-scale testing (Phase 3)Study completedNCT05440383
What this trial is testing

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Who this might be right for
Uterine Fibroids (MeSH Heading: Leiomyoma)
Kissei Pharmaceutical Co., Ltd. 287